Bladder Cancer - Results from #320

Pembrolizumab therapy for chemotherapy-resistant urothelial carcinoma - Beyond the Abstract March 9, 2017

Adjuvant chemotherapy following radical nephroureterectomy for upper tract urothelial carcinoma - Beyond the Abstract March 8, 2017

Atezolizumab in platinum-ineligible urothelial cancer patients - Beyond the Abstract March 7, 2017

A multi-institutional comparison of clinicopathologic characteristics and oncologic outcomes of upper tract urothelial carcinoma in China and the United States: Beyond the Abstract February 2, 2017

Radiation-induced complex anterior urinary fistulation for prostate cancer: a retrospective multicenter study from the Trauma and Urologic Reconstruction Network of Surgeons: Beyond the Abstract January 19, 2017

Where are we in the salvage treatment of metastatic bladder cancer?: Beyond the Abstract December 15, 2016

Comparative Effectiveness of a Patient Centered Pathology Report for Bladder Cancer Care: Beyond the Abstract December 9, 2016

Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP® peptide ex vivo: Beyond the Abstract December 5, 2016

Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer: Beyond the Abstract November 18, 2016

Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors: Beyond the Abstract November 17, 2016

Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response: Beyond the Abstract November 17, 2016

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma: Beyond the Abstract November 16, 2016

A five-gene expression signature to predict progression in T1G3 bladder cancer: Beyond the Abstract November 16, 2016

90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study: Beyond the Abstract October 28, 2016

Bladder Cancer Diagnosis from Bladder Wash by Fourier Transform Infrared Spectroscopy as a Novel Test for Tumor Recurrence: Beyond the Abstract October 18, 2016

Chemoprevention of Bladder Cancer: A Mini Review: Beyond the Abstract October 4, 2016

Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design: Beyond the Abstract October 3, 2016

Urinary metabolomics-based biological model for predicting survival of bladder cancer patients - Beyond the Abstract September 21, 2016

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. - Beyond the Abstract September 7, 2016

Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non-Muscle-Invasive Bladder Cancer: Beyond the Abstract August 3, 2016

Page 17 of 24